Dual anti-angiogenic chemotherapy with temozolomide and celecoxib in selected patients with malignant glioma not eligible for standard treatment
Aim: Due to their high rate of neo-angiogenesis, malignant gliomas may qualify for treatment with anti-angiogenic substances. We report on a series of patients with malignant glioma not eligible for standard postoperative combined radiochemotherapy due to decreased health status. Patients and Method...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 2015
|
| In: |
Anticancer research
Year: 2015, Jahrgang: 35, Heft: 9, Pages: 4955-4960 |
| ISSN: | 1791-7530 |
| DOI: | undefined |
| Online-Zugang: | Verlag, teilw. kostenfrei, Volltext: http://dx.doi.org/undefined Verlag, teilw. kostenfrei, Volltext: http://ar.iiarjournals.org/content/35/9/4955 
|
| Verfasserangaben: | Johannes Kerschbaumer, Franziska Anna Schmidt, Astrid Ellen Grams, Martha Nowosielski, Daniel Pinggera, Konstantin Robert Brawanski, Ondra Petr, Claudius Thomé, Jochen Tuettenberg, Marcel Seiz and Christian Franz Freyschlag |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1570565570 | ||
| 003 | DE-627 | ||
| 005 | 20230428184818.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180306s2015 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1570565570 | ||
| 035 | |a (DE-576)500565570 | ||
| 035 | |a (DE-599)BSZ500565570 | ||
| 035 | |a (OCoLC)1340992794 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kerschbaumer, Johannes |e VerfasserIn |0 (DE-588)1153801698 |0 (DE-627)1015317642 |0 (DE-576)500565503 |4 aut | |
| 245 | 1 | 0 | |a Dual anti-angiogenic chemotherapy with temozolomide and celecoxib in selected patients with malignant glioma not eligible for standard treatment |c Johannes Kerschbaumer, Franziska Anna Schmidt, Astrid Ellen Grams, Martha Nowosielski, Daniel Pinggera, Konstantin Robert Brawanski, Ondra Petr, Claudius Thomé, Jochen Tuettenberg, Marcel Seiz and Christian Franz Freyschlag |
| 264 | 1 | |c September 2015 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.03.2018 | ||
| 520 | |a Aim: Due to their high rate of neo-angiogenesis, malignant gliomas may qualify for treatment with anti-angiogenic substances. We report on a series of patients with malignant glioma not eligible for standard postoperative combined radiochemotherapy due to decreased health status. Patients and Methods: A total of nine patients with malignant glioma, postoperatively presenting with a Karnofsky performance score (KPS) below 70, were treated with standalone metronomic low-dose chemotherapy with temozolomide and celecoxib (cyclo-oxygenase-2 inhibitor). Overall survival was defined as the primary end-point and the functional status (KPS) and time to progression as secondary end-points of our analysis. Results: The median KPS after surgery was 60. Treatment achieved a decrease in tumor and edema volume and, more importantly, preserved the functional status defined as the ability to care for self (KPS 70%) until disease progression. No notable side-effects were recorded. Conclusion: In patients with decreased general condition (KPS <70), not eligible for standard treatment, anti-angiogenic therapy offers a reasonable alternative approach. Our results indicate prolonged survival and preserved quality of life in comparison to best supportive care. | ||
| 650 | 4 | |a celecoxib | |
| 650 | 4 | |a dual anti-angiogenic chemotherapy | |
| 650 | 4 | |a Glioblastoma | |
| 650 | 4 | |a temozolomide | |
| 700 | 1 | |a Seiz-Rosenhagen, Marcel |d 1977- |e VerfasserIn |0 (DE-588)129921807 |0 (DE-627)483655503 |0 (DE-576)297904019 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anticancer research |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004 |g 35(2015), 9, Seite 4955-4960 |h Online-Ressource |w (DE-627)387478493 |w (DE-600)2145376-7 |w (DE-576)358408717 |x 1791-7530 |7 nnas |a Dual anti-angiogenic chemotherapy with temozolomide and celecoxib in selected patients with malignant glioma not eligible for standard treatment |
| 773 | 1 | 8 | |g volume:35 |g year:2015 |g number:9 |g pages:4955-4960 |g extent:6 |a Dual anti-angiogenic chemotherapy with temozolomide and celecoxib in selected patients with malignant glioma not eligible for standard treatment |
| 856 | 4 | 0 | |u http://dx.doi.org/undefined |x Verlag |x Resolving-System |z teilw. kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://ar.iiarjournals.org/content/35/9/4955 |x Verlag |z teilw. kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180306 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 129921807 |a Seiz-Rosenhagen, Marcel |m 129921807:Seiz-Rosenhagen, Marcel |d 60000 |d 62600 |e 60000PS129921807 |e 62600PS129921807 |k 0/60000/ |k 1/60000/62600/ |p 10 | ||
| 999 | |a KXP-PPN1570565570 |e 3001854634 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Johannes Kerschbaumer, Franziska Anna Schmidt, Astrid Ellen Grams, Martha Nowosielski, Daniel Pinggera, Konstantin Robert Brawanski, Ondra Petr, Claudius Thomé, Jochen Tuettenberg, Marcel Seiz and Christian Franz Freyschlag"]},"id":{"eki":["1570565570"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"September 2015"}],"relHost":[{"name":{"displayForm":["International Institute of Anticancer Research"]},"origin":[{"dateIssuedDisp":"2004-","publisher":"International Institute of Anticancer Research","dateIssuedKey":"2004","publisherPlace":"Kapandriti, Attiki, Greece"}],"id":{"zdb":["2145376-7"],"eki":["387478493"],"issn":["1791-7530"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Anticancer research","subtitle":"international journal of cancer research and treatment","title_sort":"Anticancer research"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 26.02.13"],"disp":"Dual anti-angiogenic chemotherapy with temozolomide and celecoxib in selected patients with malignant glioma not eligible for standard treatmentAnticancer research","recId":"387478493","language":["eng"],"pubHistory":["Nachgewiesen 24.2004 -"],"part":{"volume":"35","text":"35(2015), 9, Seite 4955-4960","extent":"6","year":"2015","pages":"4955-4960","issue":"9"}}],"physDesc":[{"extent":"6 S."}],"person":[{"family":"Kerschbaumer","given":"Johannes","roleDisplay":"VerfasserIn","display":"Kerschbaumer, Johannes","role":"aut"},{"family":"Seiz-Rosenhagen","given":"Marcel","display":"Seiz-Rosenhagen, Marcel","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title":"Dual anti-angiogenic chemotherapy with temozolomide and celecoxib in selected patients with malignant glioma not eligible for standard treatment","title_sort":"Dual anti-angiogenic chemotherapy with temozolomide and celecoxib in selected patients with malignant glioma not eligible for standard treatment"}],"recId":"1570565570","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 06.03.2018"]} | ||
| SRT | |a KERSCHBAUMDUALANTIAN2015 | ||